Asia's Next Frontier: Building Capabilities for Translational Research

Asia's Next Frontier: Building Capabilities for Translational Research

Share

Details

Over the past decade, Asia has experienced great investment in biomedical research and development and, as a result, incredible advances in biomedical innovation. However, large gaps in commercializing research still exist. Is the region prepared to overcome the "Valley of Death" and translate basic research discoveries to commercial success? What is necessary to improve translational research capacity? What can be done to incentivize investments in translational research? What successful financing models are leading the way?

 

Custom Author Text

Moderator:

Tanisha Carino Executive Director, FasterCures

 

Speakers:

Christiana Bardon Managing Director, UBS Oncology Impact Fund, MPM Capital Carl Firth CEO, ASLAN Pharmaceuticals

Annalisa Jenkins Chairman, Cell Medica

Baiju Shah CEO, BioMotiv; Co-Leader, The Harrington Project for Discovery & Development

Tags
Topics
Tags
Topics
Published May 3, 2019